Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Fetal to adult haemoglobin switch is crucial for development.
• Hereditary persistence of fetal haemoglobin (HPFH) is linked to altered gamma-globin expression.
• Non-deletion HPFH suggests regulatory mutations affecting gamma-globin genes.

Purpose of the Study:

• Investigate the molecular mechanisms of non-deletion HPFH.
• Identify nuclear proteins interacting with gamma-globin promoter sequences.
• Correlate mutations with altered promoter activity in erythroid cells.

Main Methods:

• In vitro binding assays of nuclear proteins to gamma-promoter sequences.
• Site-directed mutagenesis of the gamma-globin promoter.
• Assessing promoter activity in human erythroleukaemia cells.
• Identifying erythroid-specific DNA-binding factors.

Main Results:

• An erythroid-specific factor, GF-1, binds to the -195 to -170 region of the gamma-promoter.
• GF-1 interacts with TATCT(AGATA) motifs but not the octamer sequence.
• A single base change (T to C at -175) in HPFH increases gamma-promoter activity.
• This mutation's effect is cell-specific to erythroid cells and mediated by GF-1.

Conclusions:

• Non-deletion HPFH can result from a specific mutation in the gamma-globin promoter.
• The erythroid-specific factor GF-1 plays a key role in regulating gamma-globin expression.
• This inherited disorder is caused by the interaction of GF-1 with a mutant promoter.